Insmed Incorporated (NASDAQ:INSM) Q3 2021 Earnings Conference Call October 28, 2021 8:30 AM ET Company Participants Eleanor Barisser – Associate Director, Investor Relations Will Lewis – Chairman and Chief Executive Officer Martina Flammer – Chief Medical Officer Roger Adsett – Chief Operating Officer Sara Bonstein – Chief Financial Officer Conference Call Participants Jennifer Kim – Cantor Fitzgerald Anita Dushyanth – Berenberg Capital Markets Joori Park – SVB Leerink Jeff Hung – Morgan Stanley Stephen Wil ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia 54-1972729 (State or other jurisdi ...

Insmed Inc. (NASDAQ:INSM) Q2 2021 Earnings Conference Call August 5, 2021 8:30 AM ET Company Participants Eleanor Barisser - Associate Director of IR Will Lewis - Chair and Chief Executive Officer Sara Bonstein - Chief Financial Officer Martina Flammer - Chief Medical Officer Roger Adsett - Chief Operating Officer Conference Call Participants Joseph Schwartz - SVB Leerink Lyla Youssef - Cowen and Company Anita Dushyanth - Berenberg Stephen Willey - Stifel Graig Suvannavejh - Goldman Sachs Operator Welcome t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or ...

Promising Therapies Inspired by Urgent Unmet Patient Needs 2 of the Company, PARI or the Company's other third-party manufacturers to comply with regulatory requirements related to ARIKAYCE or the Lamira® Nebulizer System; the Company's inability to obtain adequate reimbursement from government or third-party payors for ARIKAYCE or acceptable prices for ARIKAYCE; development of unexpected safety or efficacy concerns related to ARIKAYCE or the Company's product candidates; inaccuracies in the Company's estim ...

Insmed Incorporated (NASDAQ:INSM) Q1 2021 Earnings Conference Call May 6, 2021 8:30 AM ET Company Participants Eleanor Barisser - Investor Relations Will Lewis - Chair and Chief Executive Officer Martina Flammer - Chief Medical Officer Roger Adsett - Chief Operating Officer Sara Bonstein - Chief Financial Officer Conference Call Participants Joori Park - SVB Leerink Lyla Youssef - Cowen Connor Meehan - Morgan Stanley Anita Dushyanth - Berenberg Capital Graig Suvannavejh - Goldman Sachs Stephen Willey - Stif ...

(Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 000-30739 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia 54-1972729 (State or other jurisdictio ...

Table of Contents OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ For the transition period from to Commission File Number 0-30739 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 INSMED INCORPORATED (Exact name of registrant as specified in its charter) Virginia (State or other jurisdictio ...

insme Promising Therapies Inspired by Urgent Unmet Patient Needs Forward Looking Statements This presentation contains forward-looking statements that involve substantial risks and uncertainties. "Forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995, are statements that are not historical facts and involve a number of risks and uncertainties. Words herein such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," ...

Promising Therapies Inspired by Urgent Unmet Patient Needs 2 Forward Looking Statements This presentation contains forward-looking statements that involve substantial risks and uncertainties. "Forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995, are statements that are not historical facts and involve a number of risks and uncertainties. Words herein such as "may," "will," "should," "could," "would," "expects," "plans," "anticipates," "believes," "est ...